ARDELYX, INC. Shares Issued, Shares, Share-based Payment Arrangement, Forfeited
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ARDELYX, INC. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2014-12-31 was 0.00 shares.
- ARDELYX, INC. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2014-09-30 was 2.22K shares.
- ARDELYX, INC. shares issued, shares, share-based payment arrangement, forfeited for fiscal 2020 was 764.72K shares, a 44.67% increase from fiscal 2019.
- ARDELYX, INC. shares issued, shares, share-based payment arrangement, forfeited for fiscal 2019 was 528.62K shares, a 47.92% decline from fiscal 2018.
- ARDELYX, INC. shares issued, shares, share-based payment arrangement, forfeited for fiscal 2018 was 1.01M shares, a 128.06% increase from fiscal 2017.
- ARDELYX, INC. shares issued, shares, share-based payment arrangement, forfeited for fiscal 2017 was 445.03K shares, a 556.94% increase from fiscal 2016.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 3 month | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 12 month |
|---|---|---|
| 2020-12-31 | 764.72K shares 10-K · filed 2021-03-08 | |
| 2019-12-31 | 528.62K shares 10-K · filed 2020-03-06 | |
| 2018-12-31 | 1.01M shares 10-K · filed 2019-03-06 | |
| 2017-12-31 | 445.03K shares 10-K · filed 2019-03-06 | |
| 2016-12-31 | 67.74K shares 10-K · filed 2019-03-06 | |
| 2015-12-31 | 28.56K shares 10-K · filed 2018-03-14 | |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | 4.08K shares 10-K · filed 2017-02-17 |
| 2014-09-30 | 2.22K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | |
| 2013-12-31 | 6.63K shares 10-K · filed 2016-03-04 | |
| 2012-12-31 | 43.85K shares 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |